Home Stock

Stock Research: PolyNovo

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

PolyNovo

ASX:PNV AU000000PNV0
19
  • Value
    8
  • Growth
    35
  • Safety
    Safety
    36
  • Combined
    10
  • Sentiment
    48
  • 360° View
    360° View
    19
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

PolyNovo Limited is an Australia-based medical device company focused on advanced wound care, designing, developing, and manufacturing dermal regeneration solutions. Its main businesses include NovoSorb Biodegradable Temporizing Matrix (BTM) and NovoSorb MTX, used for managing various wounds. In the last fiscal year, the company had a market cap of $538 million, profits of $66 million, revenue of $70 million, and 254 employees.

more

ANALYSIS: With an Obermatt 360° View of 19 (better than 19% compared with alternatives), overall professional sentiment and financial characteristics for the stock PolyNovo are critical, mostly below average. The 360° View is based on consolidating four consolidated indicators, with all four indicators below average for PolyNovo. The consolidated Value Rank has a low rank of 8 which means that the share price of PolyNovo is on the higher side compared with typical size in indicators such as revenues, profits, and invested capital. This means the stock price is higher than for 92% of alternative stocks in the same industry. The consolidated Growth Rank also has a low rank of 35, which means that the company exhibits below-average growth momentum when looking at financial metrics such as revenue, profit, and invested capital growth as well as stock returns. This means that growth is lower than for 35% of competitors in the same industry. The consolidated Safety Rank has a riskier rank of 36, which means that the company has a riskier financing structure than 64% comparable companies when looking at the amount of its debt, its refinancing requirements, and its ability to service debt. Finally, the consolidated Sentiment Rank has a low rank of 48, which means that professional investors are more pessimistic about the stock than for 52% of alternative investment opportunities. ...read more

more
Strongest Rank Dividend Yield
Weakest Rank Pro Holdings
Country Australia
Industry Health Care Supplies
Size Small
Website polynovo.com
Index
ASX 300
PolyNovo stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 23-Jun-2026.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 7 6 3
Growth
35 56 97 45
Safety
Safety
36 15 12 4
Sentiment
48 57 51 41
360° View
360° View
19 15 23 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Analyst Opinions
70 49 55 55
Opinions Change
50 50 72 50
Pro Holdings
n/a 51 40 50
Market Pulse
6 64 53 38
Sentiment
48 57 51 41
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Value
8 7 6 3
Growth
35 56 97 45
Safety Safety
36 15 12 4
Combined
10 4 21 1
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Price vs. Sales (P/S)
46 11 9 5
Price vs. Earnings (P/E)
12 10 5 3
Price vs. Book (P/B)
13 3 3 1
Dividend Yield
1 1 1 1
Value
8 7 6 3
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Revenue Growth
72 91 96 100
Profit Growth
28 80 94 75
Capital Growth
34 1 98 1
Stock Returns
38 51 23 17
Growth
35 56 97 45
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2025 2024 2023
Leverage
60 40 41 24
Refinancing
20 9 17 5
Liquidity
46 18 12 6
Safety Safety
36 15 12 4

Similar Stocks

Discover high‑ranked alternatives to PolyNovo and broaden your portfolio horizons.

West African Resources

ASX:WAF
Country: Australia
Industry: Gold Production
Size: Medium
Full Stock Analysis

Asahi Intecc

TYO:7747
Country: Japan
Industry: Health Care Supplies
Size: Large
Full Stock Analysis

Otsukas

TYO:4578
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Shionogi

TYO:4507
Country: Japan
Industry: Pharmaceuticals
Size: X-Large
Full Stock Analysis

Frequently Asked
Questions

This is a highly risky stock investment proposition as all consolidated ranks are below-average. There are no compelling arguments to support this stock based on current information. It is not recommended for any investor profile. However, performance does change, so it could we worth keepin on a watchlist.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews